Nature Reviews Cancer - Monoclonal antibodies ... Ito, F. et al. Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines.

The most significant recent advances in the application of monoclonal antibodies (mAbs) to oncology have been the introduction and approval of bevacizumab (Avastin), an anti–vascular endothelial ...

Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the body's own immune system to fight tumors. These compounds target the ...

New research suggests that monoclonal antibody therapy of cancer can be improved to be much more powerful than it is today. Skip to main content. Your source for the latest research news.

Precision-targeted therapy via antibody drugs has become central to the field of cancer immunotherapy. Monoclonal antibodies ...

Immunomodulatory therapeutic monoclonal antibodies that bind immune cells exhibit higher anti-tumor activity when they have a looser grip on immune cell receptors.

Anti-EGFR monoclonal antibodies (MAb) combined with chemotherapy in metastatic colon cancer (mCRC) patients (pts): Meta-analysis of randomized trials. Nirit Yarom , Avishay Sella , Gillian Gresham ...

Hans Lee, MD, MD Anderson Cancer Center, ... (R/R) multiple myeloma and discusses the incorporation of anti–CD-38 monoclonal antibodies into frontline therapy. ...

Two targets, double success. This is the logic behind a new approach that uses monoclonal antibody (MAb) pairs to fight cancer. The two MAbs in the pair have different specificities and form ...

FDA Approves Anti-SARS-CoV-2 Monoclonal Antibodies For The Vaccine Insensitive Immune Suppressed Population. ... Specific groups who could benefit from the antibody drug include cancer patients, ...

A new pilot clinical study will explore the safety and effectiveness of 2 anti-canine monoclonal antibodies on solid tumors ...

Patients with cancer should talk with their doctor to determine if they would be sufficiently protected by any of the available COVID-19 vaccines or if they would be eligible for, and better off, ...